LGALS3 and diabetic kidney disease: Consequently, 15 targets were overlapped, including MMP1, CASP3AKT1, HIF1A, IL10, MMP9, PTGS2, BCL2, BAX,MMP2, PTGS1, SLC6A2, PRKCA, LGALS3, BCHE, which were predicted as the candidate targets for SAL in treatment DKD.